Asia-Pacific Pharmaceuticals

A recent conference on pharmaceuticals discussed business issues like phase III clinical trials, counterfeiting of drugs and cutting edge R&D for drug companies, but the disease scenario of the Asia-Pacific region was missing, as also the drug discovery and R&D challenges to address them.